News Implants could transform CAR-T therapy into one-day procedur... CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.